These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
621 related articles for article (PubMed ID: 28235986)
21. Stable core virome despite variable microbiome after fecal transfer. Broecker F; Russo G; Klumpp J; Moelling K Gut Microbes; 2017 May; 8(3):214-220. PubMed ID: 27935413 [TBL] [Abstract][Full Text] [Related]
22. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection. Zuo T; Wong SH; Cheung CP; Lam K; Lui R; Cheung K; Zhang F; Tang W; Ching JYL; Wu JCY; Chan PKS; Sung JJY; Yu J; Chan FKL; Ng SC Nat Commun; 2018 Sep; 9(1):3663. PubMed ID: 30202057 [TBL] [Abstract][Full Text] [Related]
23. Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota. Staley C; Vaughn BP; Graiziger CT; Singroy S; Hamilton MJ; Yao D; Chen C; Khoruts A; Sadowsky MJ Gut Microbes; 2017 May; 8(3):276-288. PubMed ID: 28282270 [TBL] [Abstract][Full Text] [Related]
24. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection. Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956 [TBL] [Abstract][Full Text] [Related]
25. Fecal Microbiota Therapy With a Focus on Clostridium difficile Infection. Brandt LJ Psychosom Med; 2017 Oct; 79(8):868-873. PubMed ID: 28976455 [TBL] [Abstract][Full Text] [Related]
26. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes. Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098 [TBL] [Abstract][Full Text] [Related]
27. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? Zhou Y; Xu H; Huang H; Li Y; Chen H; He J; Du Y; Chen Y; Zhou Y; Nie Y Biomed Res Int; 2019; 2019():3469754. PubMed ID: 31467881 [TBL] [Abstract][Full Text] [Related]
28. Fecal Microbiota Transplantation for the Critically Ill Patient. Limketkai BN; Hendler S; Ting PS; Parian AM Nutr Clin Pract; 2019 Feb; 34(1):73-79. PubMed ID: 30561131 [TBL] [Abstract][Full Text] [Related]
29. Fecal microbial transplantation as a therapeutic option in patients colonized with antibiotic resistant organisms. Laffin M; Millan B; Madsen KL Gut Microbes; 2017 May; 8(3):221-224. PubMed ID: 28059612 [TBL] [Abstract][Full Text] [Related]
30. Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Leung V; Vincent C; Edens TJ; Miller M; Manges AR Clin Infect Dis; 2018 Jan; 66(3):456-457. PubMed ID: 29020222 [TBL] [Abstract][Full Text] [Related]
31. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease. Newman KM; Rank KM; Vaughn BP; Khoruts A Gut Microbes; 2017 May; 8(3):303-309. PubMed ID: 28102756 [TBL] [Abstract][Full Text] [Related]
32. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity. Carlucci C; Petrof EO; Allen-Vercoe E EBioMedicine; 2016 Nov; 13():37-45. PubMed ID: 27720396 [TBL] [Abstract][Full Text] [Related]
33. Fecal microbiota transplantation in cancer management: Current status and perspectives. Chen D; Wu J; Jin D; Wang B; Cao H Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058 [TBL] [Abstract][Full Text] [Related]
34. The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future. Allegretti J; Eysenbach LM; El-Nachef N; Fischer M; Kelly C; Kassam Z Inflamm Bowel Dis; 2017 Oct; 23(10):1710-1717. PubMed ID: 28858073 [TBL] [Abstract][Full Text] [Related]
35. Fecal microbiota transplantation for Clostridium difficile infection in Taiwan: Establishment and implementation. Lin TC; Hung YP; Ko WC; Ruan JW J Microbiol Immunol Infect; 2019 Dec; 52(6):841-850. PubMed ID: 31607571 [TBL] [Abstract][Full Text] [Related]
36. Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation. DuPont HL; Jiang ZD; DuPont AW; Utay NS Dig Dis Sci; 2020 Mar; 65(3):741-756. PubMed ID: 32008133 [TBL] [Abstract][Full Text] [Related]
37. Fecal microbiota transplantation in metabolic syndrome: History, present and future. de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252 [TBL] [Abstract][Full Text] [Related]
38. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T Digestion; 2017; 96(1):29-38. PubMed ID: 28628918 [TBL] [Abstract][Full Text] [Related]